Exam 2: Migraines Flashcards
____ is a common, recurrent, severe headache that interferes with normal function
Migraine
Episodic migraine is ___ monthly migraine days (MMDs) or monthly headaches days (MHDs)
<15
Chronic migraine is ____ MHDs for ≥3 months (≥8 days are MMDs)
≥15
____ is a complex of positive and negative focal neurologic symptoms that precedes or accompanies an attack
Aura
Aura: scintillations def
Vision with a shimmering, twinkling or wavy effect; vision in the area of the shimmer is impaired
Aura: Photopsia def
Flashing lights
Aura: Telchopsia def
A transient visual sensation of bright shimmering colors
Aura: Fortification spectrum def
Flashing, brightly colored lights in a zigzag pattern that typically start in the middle of the visual field move outward
Aura: Scotoma def
a blind spot in the field of vision
Aura: Hemianopsia def
blindness or reduction in vision in one half of the visual field
____ self-sustaining cycle of headache sin which the headache returns when the medication wares off, leading to use more meds which perpetuates the cycle – increased headache freq and med consumption
Medication overuse headache
Primary headache types (classifications)
Sinus
Cluster
Tension
Migraine
Secondary headache types (classification)
Head trauma Stroke Infections Substance abuse/withdrawal Craniofacial structure disorders
____ headaches occur usually behind the forehead and/or cheekbones
Sinus
____ headaches occur in and around one eye
Cluster
____ headache occurs like a band squeezing the head
Tension
____ headache usually has pain, nausea, and visual changes
Migraine
Tension type headache characteristics
Over the top of the head, extending to the base of the skull
Varies from diffuse ache to tight, pressing, constricting pain
Gradual
Duration: Min to days
Migraine Headache characteristics
Usually unilateral
Throbbing pain, maby be preceded by an aura
Sudden onset
Duration: Hours to 2 days
Sinus headache characteristics
Face, forehead or periorbital area
Pressure behind eyes or face, dull bilateral pain – worse in the morning
Simultaneous with sinus symptoms including purulent nasal discharge
Duration: Days (resolves with sinus symptoms)
Risk factors for migraines
F > M Age 30s-40s Lower socioeconomic status FHx Diet (red wine, cured meats) Co-morbidities (neurologica disorders, psychiatric disorders, CV disorders)
Acute Migraine Pathophysiology
External trigger > neuronal dysfuncton > vasodilation > activation of trigeminal nerves > neuropeptide release > inflammation
Lifestyle triggers for migraines
Stress Lack of sleep or oversleeping Fasting/skipping meals Overexertion Travel Caffeine (>200mg/day) or withrdrawal Sexual activity.
Food triggers for migraines
Chocolate Processed meats Fermented and pickled foods MSG Tyramine containing foods ASpartame containing foods Alcohol
Environmental triggers of migraines
Weather or seasonal changes Bright or flickering lights Strong odors Change in altitude Loud noises
Physical triggers of migraines
Menstruation or other hormonal changes
Headache usually begins within ___ min of aura
60
Acute migraine s/sx
Absence of daily headache
Normal neurologic examination
FHx migraine
Trigger association
Throbbing head pain
Unilateral (often)
Gradual in onset but peaks after minutes to hours
Begins most often in early morning hours
May last 4-72hrs
N/V
Sensitivity to light, sound, and/or movement
T/F: Migraines usually occur at night
False - usually in early morning hours
Migraine: POUND mnemonic
Pulsatile quality One day duration (4-72hrs) Unilateral N/V Disabling
aura positive symptoms
Scintillation
Photopsia
Teichopsia
Fortification spectrum
Aura negative symptoms
Scotoma
Hemianopsia
Diagnosis of migraine without aura
At least 5 attacks
Headache lasted 4-72hrs
At least 2 of the following:
-unilateral location, pulsing quality, moderate or severe intensity, aggravation by or avoidance of routine physical activity
And 1 of the following
-N/V, photophobia, phonophobia, not attributable to another disorder
Diagnosis of migraine with aura
at least 2 attacks
Migraine aura fulfills criteria for typical, hemiphlegic, or basilar-type
Not attributable to another disorder
Typical aura
- fully reversible visual, sensory, or speech symptoms but no motor weakness
- homonymous or bilateral visual symptoms or unilateral sensory symptoms including positive or negative features or any combination
- at least 2 of the following: at least one symptom that develops gradually over at least 5min or diff symptoms occur in succession in both, each symptom lasts for at least 5 min and for no longer than 60 min, headache that meets criteria for migraine without aura begins during the aura or follows the aura within 60 min
Migraine non-pharmacologic therapy
Cold compresses Rest or sleep Quiet, dark environment Devices Identification and avoidance of triggers Behavioral interventions (relaxation techniques, acupuncture, wellness programs)
Trigger avoidance tips
Migraine logs.
Non-pharmacological devices for migraines age limits
≥12yo : Nerivio, Spring TMs, gammaCore
≥18yo: Relivion, Cefaly
Which non-pharmacological devices for migraines are for treatment only
Nerivio and Relivion MG
Which non-pharmacological devices for migraines are for treatment and prevention/
Spring TMS, gammaCore, Cefaly
Goals of Therapy for Acute Migraines
Restore ability to function Treat attacks rapidly and consistently Minimize the use of backup/rescue medications Optimize self-care Utilize cost-effective management Cause minimal to no side effects
Who are NOT candidates for self care of migraines
Recent trauma Complaints of confusion, drowsiness, cognitive impairment, peripheral numbness/weakness Fever Onset at >50 yo Under age 18 Hx of liver disease or alc abuse
Acute migraines: 2 treatment approaches
STEP-UP: Use of NSAIDs and combination products first, reserving other therapies
STRATIFIED CARE: initial migraine treatment is based on symptom severity and headache-related disability
According to the DISC study, of the 2 treatment approaches of acute migraines, ____ produced better results than ____
Stratified > step care
5-HT Agonists (Triptans) MOA
Vasoconstriction via activation of postsynaptic 5-HT1B receptors of the smooth muscle of blood vessels
Presynaptic 5-HT1D receptors activity leading to blockade of release of vasoactive peptides from the trigeminal neurons
Presynaptic 5-HT1D receptors activity leading to blockade of NT and activation of second-order neurons – may facilitate descending pain inhibitory systems
Sumatriptan brand name tab
Imitrex
Sumatriptan brand name nasal spray
Imitrex, Tosymra
Sumatriptan brand name nasal powder
Onzetra Xsail
Sumatriptan Brand name SQ injection
Alsuma, Imitrex, Sumavel, Zenbrace Smytouch
Sumatriptan DDIs
Avoid use w/in 2 weeks of MAOi like isocarboxaid, phenlzine, selegilline, tranylcyp-romine
Sumatriptan clinical considerations
Max PO dose 50mg with mild-mod hepatic impairment (NOT recommended for severe hepatic impairment)
SQ sumatriptan has fastest onset of action (~10min) and has best efficacy data
Sumatriptan-Naproxen sodium brand name tab
Treximet
Zolmitriptan brand name
Zomig
Zolmitriptan dosage forms
Tab, oral dissolving wafer, nasal spray
Zolmitriptan DDIs
Avoid use w/in 2 weeks MAOis
Max single dose 2.5mg and Max total dose 5mg when used with cimetidine
Zolmitriptan clinical considerations
No renal adj
CYP1A2
Max PO dose of 1.25mg (max total dose 5mg) with mod-severe hepatic impairment
Avoid ODT and nasal spray in mod-severe hepatic impairment
Almotriptan brand name
Axert
Almotriptan dosage form
Tab
Almotriptan DDI
Reduce dose to 6.25mg when used with potent CYP3A4 inhibitor (like ketoconazole)
Almotriptan Clinical Considerations
Contains sulfa group (Allergy!)
Dose adj for renal/hepatic impairment: start dose 6.25mg max of 12.5mg/24h
Eletriptan brand name
Replax
Eletriptab dosage form
Tab
Eletriptan DDIs
Should not be used within 3 days of potent CYP3A4 inhibitors
Eletriptan should not be used within ___ days of potent CYP___ inhibitors
3 days of 3A4 inhibitors
Eletriptan clinical considerations
Avoid use in severe hepatic impairment
CYP3A4
Rizatriptan brand name
Maxalt
Rizatriptan dosage forms
Tab, oral dissolving wafer
Rizatriptan DDIs
5mg/dose and max 3 doses/24hrs when used with propranolol
Do not use w/in 2 weeks of MAOi
Which triptan is contraindicated in pts with a sulfa allergy?
Almotriptan
Which triptans come as oral dissolving wafer?
Zolmitriptan
Rizatriptan
Frovatriptan brand name
Frova
Naratriptan brand name
Amarge
___ is considered less effective than other triptans
Frovatriptan
Frovatriptan clinical considerations
Considered less effective than other triptans
Slower onset and longer duration of action
CYP1A2
Naratriptan clinical considerations
Similar to frovatriptan (Less efficacious and slower onset)
Mild-moderate renal impairment start lower dose
CI for CrCl <15
Child-Pugh dosing adj
Various CYP enzymes
Triptans contraindication
Hx CAD, angina, vasopastic angina, uncontrolled HTN, cerebrovascular disease, peripheral vascular disease, hemiplegic/basilar migraine, hepatic disease (sumatriptan, zolmitiptan, eletriptan, and naratriptan)
Triptan ADEs
Fatigue, dizziness, flushing, warm sensations, somnolence, paresthesias, chest/neck symptoms (may go away if you switch triptans or meds)
Medication overuse headache
Triptan DDIs
Within 24 hrs ergot alkaloids
within 2 weeks of MAOi
Potential for serotonin syndrome (fluoxetine, sertraline, venlafaxine)
Meds with Serotonin Syndrome
MAOis, trazodone, SSRIs, SNRIs, TCAs, Triptans, Ditans, valproate
Tramadol, meperidine
5-HT3 antagonists (ondansetron), metoclopramide
Linezolid
Triptan place in thearpy
Mod-severe mirgaine with no contraindications
Severe migraines which responded poorly to NSAIDs or combo analgesics
Triptans clinical considerations
Start at low doses for geriatric pts, many have renal/hepatic dose adj
1/3 of pts do not respond to triptan monotherapy
If ineffective: increase dose, try another triptan, try another formulation, combo, try diff therapy
Oral triptan patient education
Onset of action: 20-60min
May repeat a dose after a certain amt of time
Max dosing